Overview
Subdoligranulum variabile is a strictly anaerobic, non-spore-forming, Gram-negative-staining bacterium belonging to the family Ruminococcaceae within the phylum Firmicutes. It is currently the only described species in the genus Subdoligranulum and is a butyrate-producing member of the healthy human gut microbiome. Research suggests that S. variabile may serve as an important biomarker of metabolic health, with its abundance positively correlated with HDL cholesterol and microbial diversity, and negatively correlated with multiple inflammatory and metabolic disease markers.
Classification
S. variabile was first isolated from human feces in 2004 and placed in the newly created genus Subdoligranulum within the Ruminococcaceae family. It is the sole species in this genus, reflecting the difficulty of isolating related organisms from the gut environment. Researchers attempting to culture additional Subdoligranulum strains during a two-year isolation effort instead discovered the entirely new genus Dysosmobacter, highlighting the extreme difficulty of culturing this organism outside its natural host environment.
Key Characteristics
S. variabile produces butyrate as a primary metabolic end product, contributing to colonocyte energy supply and anti-inflammatory signaling in the colon. The type strain DSM 15176 (also designated BI 114T) is a strict anaerobe with Gram-negative staining despite belonging to the traditionally Gram-positive Firmicutes phylum. Comprehensive human cohort analyses have shown that Subdoligranulum abundance is positively correlated with bacterial richness (a marker of microbiome diversity) and HDL cholesterol, while being negatively correlated with fat mass, adipocyte diameter, leptin, insulin, C-reactive protein (CRP), and interleukin-6 (IL-6).
Health Significance
S. variabile depletion has been consistently documented across metabolic disease states. Analysis of 946 microbiome profiles (272 type 2 diabetes patients vs. 674 controls) confirmed its consistent depletion in T2D, with six butyrate fermentation pathways involving Subdoligranulum identified as significant discriminators between healthy and diabetic states. Its negative correlation with gut permeability markers in cirrhosis and alcoholism further supports its role as a gut barrier integrity indicator. While in vivo mouse supplementation with S. variabile did not significantly alter obesity hallmarks despite butyrate production, this may reflect the need for strain or dose optimization. The species appears to be a reliable indicator of a healthy, diverse gut ecosystem, though interventional studies are still needed to determine whether its supplementation can directly improve metabolic outcomes.